MARVIN WALKER SEXTON MD NPI 1659365138

NPI Details

Marvin Walker Sexton, MD is a pulmonary disease internal medicine in Dothan, AL with 29 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. Marvin Walker Sexton, MD NPI is 1659365138. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Graduation Year:1996

The provider's business location address is:

1450 ROSS CLARK CIR STE 400
DOTHAN, AL
ZIP 36301-770
Phone: (334) 305-0400
Fax: (334) 305-0401

The NPI 1659365138 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Test to examine how well the lungs exchange gases (HCPCS:94729)
• X-ray of chest, 2 views (HCPCS:71046)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Sleep study in sleep lab with continuous airway pressure (6 years or older) (HCPCS:95811)
• Sleep study including heart rate, breathing, airflow, and effort (HCPCS:95806)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Test to determine lung volumes using sensors (HCPCS:94726)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Sleep study in sleep lab (6 years or older) (HCPCS:95810)
• Adm sarscov2 50 mcg/.5 mlbst (HCPCS:0094A)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Evaluation of use of breathing device (HCPCS:94664)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Test for exercise-induced lung stress (HCPCS:94618)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes (HCPCS:99152)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Injection, bebtelovimab, 175 mg (HCPCS:Q0222)
• Sleep study including heart rate, breathing, airflow, and effort (HCPCS:95806)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
• Biopsy of lobe of lung using an endoscope, 1 lobe (HCPCS:31628)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Irrigation and suction of lung airways to obtain cells using an endoscope (HCPCS:31624)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)

The enumeration date for this NPI number is 9/9/2005 and was last updated on 7/21/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.